Skip to content

LBRX LBRX Net Income

Net Income at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$2.68B+9.0%
Alkermes logo
AlkermesALKS
-$66.48M-396%
MapLight Therapeutics, Inc.
 logo
MapLight Therapeutics, Inc. MPLT
-$60.67M-172%
Alto Neuroscience logo
Alto NeuroscienceANRO
-$26.24M-73.0%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$37.89M+1,323%
Opko Health logo
Opko HealthOPK
-$54.85M+18.9%

Other financials

Income statement

See full
EPS (diluted)-$0.67+95.5%

Balance sheet

See full
Cash & equivalents$320.7M
Total debt$3.5M
Total equity$378.7M+481%
Total assets$393.5M

Cash flow

See full
Operating cash flow-$23.3M-187%
CapEx$32.0K+52.4%
Free cash flow-$23.3M-186%

Valuation

See full
Market cap$874.06M+159%
Enterprise value$556.86M

Returns & leverage

See full
Return on equity-27.9%
Debt / equity
Current ratio35.7×

Where this comes from

Reported directly by LBRX in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: LBRX’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about LBRX's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LBRX's net income?
LBRX (LBRX) reported net income of -$19.05M in Q1 2026.
How has LBRX's net income changed year-over-year?
LBRX's net income decreased by 259.1% year-over-year, from -$5.31M to -$19.05M.
What does net income mean?
The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.